Protagonist Therapeutics Stock Forward View - Accumulation Distribution
| PTGX Stock | USD 81.49 0.44 0.54% |
Protagonist Stock outlook is based on your current time horizon.
At this time the rsi of Protagonist Therapeutics' share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 3.513 | EPS Estimate Next Quarter (0.62) | EPS Estimate Current Year (1.87) | EPS Estimate Next Year 1.5691 | Wall Street Target Price 101.9167 |
Using Protagonist Therapeutics hype-based prediction, you can estimate the value of Protagonist Therapeutics from the perspective of Protagonist Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Protagonist Therapeutics using Protagonist Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Protagonist using crowd psychology based on the activity and movement of Protagonist Therapeutics' stock price.
Protagonist Therapeutics Short Interest
An investor who is long Protagonist Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Protagonist Therapeutics and may potentially protect profits, hedge Protagonist Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 67.1923 | Short Percent 0.1558 | Short Ratio 9.74 | Shares Short Prior Month 8.3 M | 50 Day MA 85.3938 |
Protagonist Relative Strength Index
Protagonist Therapeutics Hype to Price Pattern
Investor biases related to Protagonist Therapeutics' public news can be used to forecast risks associated with an investment in Protagonist. The trend in average sentiment can be used to explain how an investor holding Protagonist can time the market purely based on public headlines and social activities around Protagonist Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Protagonist Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Protagonist Therapeutics.
Protagonist Therapeutics Implied Volatility | 0.62 |
Protagonist Therapeutics' implied volatility exposes the market's sentiment of Protagonist Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Protagonist Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Protagonist Therapeutics stock will not fluctuate a lot when Protagonist Therapeutics' options are near their expiration.
Protagonist Therapeutics after-hype prediction price | USD 81.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Protagonist | Build AI portfolio with Protagonist Stock |
Prediction based on Rule 16 of the current Protagonist contract
Based on the Rule 16, the options market is currently suggesting that Protagonist Therapeutics will have an average daily up or down price movement of about 0.0388% per day over the life of the 2026-04-17 option contract. With Protagonist Therapeutics trading at USD 81.49, that is roughly USD 0.0316 . If you think that the market is fully incorporating Protagonist Therapeutics' daily price movement you should consider acquiring Protagonist Therapeutics options at the current volatility level of 0.62%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Protagonist Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Protagonist Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Protagonist Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Protagonist Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Protagonist Therapeutics' open interest, investors have to compare it to Protagonist Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Protagonist Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Protagonist. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Protagonist Therapeutics Additional Predictive Modules
Most predictive techniques to examine Protagonist price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Protagonist using various technical indicators. When you analyze Protagonist charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 17692.87 | 0.0413 |
| Check Protagonist Therapeutics Volatility | Backtest Protagonist Therapeutics | Information Ratio |
Protagonist Therapeutics Trading Date Momentum
| On February 17 2026 Protagonist Therapeutics was traded for 81.49 at the closing time. The top price for the day was 84.06 and the lowest listed price was 80.59 . There was no trading activity during the period 0.0. Lack of trading volume on February 17, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.61% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Protagonist Therapeutics to competition |
Other Forecasting Options for Protagonist Therapeutics
For every potential investor in Protagonist, whether a beginner or expert, Protagonist Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Protagonist Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Protagonist. Basic forecasting techniques help filter out the noise by identifying Protagonist Therapeutics' price trends.Protagonist Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Protagonist Therapeutics stock to make a market-neutral strategy. Peer analysis of Protagonist Therapeutics could also be used in its relative valuation, which is a method of valuing Protagonist Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Protagonist Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Protagonist Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protagonist Therapeutics shares will generate the highest return on investment. By undertsting and applying Protagonist Therapeutics stock market strength indicators, traders can identify Protagonist Therapeutics entry and exit signals to maximize returns.
Protagonist Therapeutics Risk Indicators
The analysis of Protagonist Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Protagonist Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting protagonist stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.62 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.28 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Protagonist Therapeutics
The number of cover stories for Protagonist Therapeutics depends on current market conditions and Protagonist Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Protagonist Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Protagonist Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Protagonist Therapeutics Short Properties
Protagonist Therapeutics' future price predictability will typically decrease when Protagonist Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Protagonist Therapeutics often depends not only on the future outlook of the potential Protagonist Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Protagonist Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.1 M | |
| Cash And Short Term Investments | 418.9 M |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.